Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-017375
Filing Date
2021-04-29
Accepted
2021-04-29 16:46:30
Documents
1
Period of Report
2021-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4281
  Complete submission text file 0000899243-21-017375.txt   5829
Mailing Address 200 LOTHROP STREET PITTSBURGH PA 15213
Business Address 200 LOTHROP STREET PITTSBURGH PA 15213 (412) 647-8762
UPMC (Reporting) CIK: 0001644244 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21871503

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations